Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome

Clinical Endocrinology

Volumn 65, Issue 1, 2006, Pages 9-16

  Mizusawa, Noriko ^a   Uchino, Shinya ^b   Iwata, Takeo ^a   Tsuyuguchi, Masaru ^l   Suzuki, Yasuyo ^c   Mizukoshi, Tsunenori ^c   Yamashita, Yoshio ^d   Sakurai, Akihiro ^e   Suzuki, Shinichi ^f   Beniko, Mutsuo ^g   Tahara, Hideki ^h   Fujisawa, Masato ⁱ   Kamata, Nobuyuki ^j   Fujisawa, Kenji ^a   Yashiro, Tohru ^k   Nagao, Daisuke ^a   Golam, Hossain Md ^a   Sano, Toshiaki ^a   Noguchi, Shiro ^b   Yoshimoto, Katsuhiko ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b Noguchi Thyroid Clinic and Hospital Foundation   (Japan)

^c SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d SAGA UNIVERSITY   (Japan)

^e SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^g Kin I Kyo Sapporo Hospital   (Japan)

^h OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ KAWASAKI MEDICAL SCHOOL   (Japan)

^j HIROSHIMA UNIVERSITY   (Japan)

^k UNIVERSITY OF TSUKUBA   (Japan)

^l TOKUSHIMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; CALCIUM; CALCIUM SENSING RECEPTOR; COMPLEMENTARY DNA; GENE PRODUCT; GENOMIC DNA; MICROSATELLITE DNA; PARAFIBROMIN; PARATHYROID HORMONE; RNA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CASR GENE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DNA METHYLATION; FAMILIAL DISEASE; FAMILIAL ISOLATED PRIMARY HYPERPARATHYROIDISM; FEMALE; FRAMESHIFT MUTATION; GENE; GENE MUTATION; GENETIC ANALYSIS; GERM LINE; HETEROZYGOSITY LOSS; HRPT2 GENE; HUMAN; HUMAN CELL; HYPERPARATHYROIDISM JAW TUMOR SYNDROME; JAW TUMOR; MALE; MEN1 GENE; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PANORAMIC RADIOGRAPHY; PARATHYROID ADENOMA; PARATHYROID CARCINOMA; POLYMERASE CHAIN REACTION; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; PROMOTER REGION; SOMATIC MUTATION; SYNDROME;

ADENOMA; ADULT; AGED; DNA MUTATIONAL ANALYSIS; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENES, TUMOR SUPPRESSOR; GENOTYPE; GERM-LINE MUTATION; HUMANS; HYPERPARATHYROIDISM, PRIMARY; JAW NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; METHYLATION; MICROSATELLITE REPEATS; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; MUTATION; PARATHYROID NEOPLASMS; PEDIGREE; PROMOTER REGIONS (GENETICS); PROMOTER REGIONS, GENETIC; RECEPTORS, CALCIUM-SENSING; SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEINS;

EID: 33745207986     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02534.x     Document Type: Article

References (37)

1. Marx S.J. ( 2005) Molecular genetics of multiple endocrine neoplasia types 1 and 2. Nature Reviews. Cancer, 5, 367 375.
2. Brown E.M. MacLeod R.J. ( 2001) Extracellular calcium sensing and extracellular calcium signaling. Physiological Reviews, 81, 239 297.
3. Simonds W.F. James-Newton L.A. Agarwal S.K. Yang B. Skarulis M.C. Hendy G.N. Marx S.J. ( 2002) Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindreds. Medicine, 81, 1 26.
4. Bradley K.J. Hobbs M.R. Buley I.D. Carpten J.D. Cavaco B.M. Fares J.E. Laidler P. Manek S. Robbins C.M. Salti I.S. Thompson N.W. Jackson C.E. Thakker R.V. ( 2005) Uterine tumours are a phenotypic manifestation of the hyperparathyroidism-jaw tumour syndrome. Journal of Internal Medicine, 257, 18 26.
5. Carpten J.D. Robbins C.M. Villablanca A. Forsberg L. Presciuttini S. Bailey-Wilson J. Simonds W.F. Gillanders E.M. Kennedy A.M. Chen J.D. Agarwal S.K. Sood R. Jones M.P. Moses T.Y. Haven C. Petillo D. Leotlela P.D. Harding B. Cameron D. Pannett A.A. Hoog A. Heath H. James-Newton L.A. Robinson B. Zarbo R.J. Cavaco B.M. Wassif W. Perrier N.D. Rosen I.B. Kristoffersson U. Turnpenny P.D. Farnebo L.O. Besser G.M. Jackson C.E. Morreau H. Trent J.M. Thakker R.V. Marx S.J. Teh B.T. Larsson C. Hobbs M.R. ( 2002) HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nature Genetics, 32, 676 680.
6. Howell V.M. Haven C.J. Kahnoski K. Khoo S.K. Petillo D. Chen J. Fleuren G.J. Robinson B.G. Delbridge L.W. Philips J. Nelson A.E. Krause U. Hammje K. Dralle H. Hoang-Vu C. Gimm O. Marsh D.J. Morreau H. Teh B.T. ( 2003) HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours. Journal of Medical Genetics, 40, 657 663.
7. Cavaco B.M. Guerra L. Bradley K.J. Carvalho D. Harding B. Oliveira A. Santos M.A. Sobrinho L.G. Thakker R.V. Leite V. ( 2004) Hyperparathyroidism-jaw tumor syndrome in Roma families from Portugal is due to a founder mutation of the HRPT2 gene. Journal of Clinical Endocrinology and Metabolism, 89, 1747 1752.
8. Cetani F. Pardi E. Borsari S. Viacava P. Dipollina G. Cianferotti L. Ambrogini E. Gazzerro E. Colussi G. Berti P. Miccoli P. Pinchera A. Marcocci C. ( 2004) Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors. Journal of Clinical Endocrinology and Metabolism, 89, 5583 5591.
9. Bradley K.J. Cavaco B.M. Bowl M.R. Harding B. Young A. Thakker R.V. ( 2005) Utilisation of a cryptic non-canonical donor splice site of the gene encoding PARAFIBROMIN is associated with familial isolated primary hyperparathyroidism. Journal of Medical Genetics, 42, e51.
10. Moon S.D. Park J.H. Kim E.M. Kim J.H. Han J.H. Yoo S.J. Yoon K.H. Kang M.I. Lee K.W. Son H.Y. Kang S.K. Oh S.J. Kim K.M. Yoon S.J. Park J.G. Kim I.J. Kang H.C. Hong S.W. Kim K.R. Cha B.Y. ( 2005) A novel IVS2-1G>A mutation causes aberrant splicing of the HRPT2 gene in a family with hyperparathyroidism- jaw tumor syndrome. Journal of Clinical Endocrinology and Metabolism, 90, 878 883.
11. Shattuck T.M. Valimaki S. Obara T. Gaz R.D. Clark O.H. Shoback D. Wierman M.E. Tojo K. Robbins C.M. Carpten J.D. Farnebo L.O. Larsson C. Arnold A. ( 2003) Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. New England Journal of Medicine, 349, 1722 1729.
12. Fujimori M. Shirahama S. Sakurai A. Hashizume K. Hama Y. Ito K. Shingu K. Kobayashi S. Amano J. Fukushima Y. ( 1998) Novel V184E MEN1 germ-line mutation in a Japanese kindred with familial hyperparathyroidism. American Journal of Medical Genetics, 80, 221 222.
13. Pannett A.A. Kennedy A.M. Turner J.J. Forbes S.A. Cavaco B.M. Basset J.H. Cianferotti L. Harding B. Shine B. Flinter F. Maidment C.G. Trembath R. Thakker R.V. ( 2003) Multiple endocrine neoplasia type 1 (MEN1) germ-line mutations in familial isolated hyperparathyroidism. Clinical Endocrinology, 58, 639 646.
14. Teh B.T. Esapa C.T. Houlston R. Grandell U. Farnebo F. Nordenskjold M. Pearce C.J. Carmichael D. Larsson C. Harris P.E. ( 1998) A family with isolated hyperparathyroidism segregating a missense MEN1 mutation and showing loss of the wild-type alleles in the parathyroid tumors. American Journal of Human Genetics, 63, 1544 1549.
15. Cetani F. Pardi E. Ambrogini E. Lemmi M. Borsari S. Cianferotti L. Vignali E. Viacava P. Berti P. Mariotti S. Pinchera A. Marcocci C. ( 2006) Genetic analyses in familial isolated hyperparathyroidism: implication for clinical assessment and surgical management. Clinical Endocrinology, 64, 146 152.
16. Simonds W.F. Robbins C.M. Agarwal S.K. Hendy G.N. Carpten J.D. Marx S.J. ( 2004) Familial isolated hyperparathyroidism is rarely caused by germ-line mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome. Journal of Clinical Endocrinology and Metabolism, 89, 96 102.
17. Villablanca A. Calender A. Forsberg L. Hoog A. Cheng J.D. Petillo D. Bauters C. Kahnoski K. Ebeling T. Salmela P. Richardson A.L. Delbridge L. Meyrier A. Proye C. Carpten J.D. Teh B.T. Robinson B.G. Larsson C. ( 2004) Germline and de novo mutations in the HRPT2 tumour suppressor gene in familial isolated hyperparathyroidism (FIHP). Journal of Medical Genetics, 41, e32.
18. Warner J. Epstein M. Sweet A. Singh D. Burgess J. Stranks S. Hill P. Perry-Keene D. Learoyd D. Robinson B. Birdsey P. Mackenzie E. Teh B.T. Prins J.B. Cardinal J. ( 2004) Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications. Journal of Medical Genetics, 41, 155 160.
19. Yoshimoto K. Endo H. Tsuyuguchi M. Tanaka C. Kimura T. Iwahana H. Kato G. Sano T. Itakura M. ( 1998) Familial isolated primary hyperparathyroidism with parathyroid carcinomas: clinical and molecular features. Clinical Endocrinology, 48, 67 72.
20. Yamashita K. Suzuki S. Yumita W. Ikeo Y. Uehara Y. Minemura K. Sakurai A. Hashizume K. ( 2001) A case of familial isolated hyperparathyroidism with ectopic parathyroid cancer. Endocrine Journal, 48, 453 458.
21. Beniko M. Matsuda A. Inoue A. Ikota A. Koizumi S. Mashio Y. Matsuge S. Sasaki Y. Watanabe K. Takahashi Y. Hai T. Kosugi S. ( 2000) Familial isolated primary hyperparathyroidism: a case report and literature review. Endocrine Surgery, 17, 105 111. (Article in Japanese, English abstract).
22. Inoue H. Miki H. Oshimo K. Tanaka K. Monden Y. Yamamoto A. Kagawa S. Sano N. Hayashi E. Nagayama M. Hayashi Y. ( 1995) Familial hyperparathyroidism associated with jaw fibroma: case report and literature review. Clinical Endocrinology, 43, 225 229.
23. Yamashita Y. Shikimori M. Goto M. (2004) A case of primary hyperparathyroidism found on the treatment of cement-ossifying fibroma in the maxillary bone. Japanese Journal of Oral Diagnosis/Oral Medicine, 17, 241 245. (Article in Japanese, English abstract).
24. Matsuki T. Nishiura H. Jo Y. Kinoshita H. Morioka M. Tanaka H. ( 2000) Familial isolated hyperparathyroidism: a report of two cases. Nippon Hinyokika Gakkai Zasshi, 91, 33 36. (Article in Japanese, English abstract).
25. Qian Z.R. Sano T. Yoshimoto K. Yamada S. Ishizuka A. Mizusawa N. Horiguchi H. Hirokawa M. Asa S.L. ( 2005) Inactivation of RASSF1A tumor suppressor gene by aberrant promoter hypermethylation in human pituitary adenomas. Laboratory Investigation, 85, 464 473.
26. Mallette L.E. Malini S. Rappaport M.P. Kirkland J.L. ( 1987) Familial cystic parathyroid adenomatosis. Annals of Internal Medicine, 107, 54 60.
27. Bassett J.H. Forbes S.A. Pannett A.A. Lloyd S.E. Christie P.T. Wooding C. Harding B. Besser G.M. Edwards C.R. Monson J.P. Sampson J. Wass J.A. Wheeler M.H. Thakker R.V. ( 1998) Characterization of mutations in patients with multiple endocrine neoplasia type American Journal of Human Genetics, 62, 232 244.
28. Cavaco B.M. Barros L. Pannett A.A. Ruas L. Carvalheiro M. Ruas M.M. Krausz T. Santos M.A. Sobrinho L.G. Leite V. Thakker R.V. ( 2001) The hyperparathyroidism-jaw tumour syndrome in a Portuguese kindred. Quarterly Journal of Medicine, 94, 213 222.
29. Haven C.J. Wong F.K. van Dam E.W. van der Juijt R. van Asperen C. Jansen J. Rosenberg C. de Wit M. Roijers J. Hoppener J. Lips C.J. Larsson C. Teh B.T. Morreau H. ( 2000) A genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumour syndrome. Journal of Clinical Endocrinology and Metabolism, 85, 1449 1454.
30. Yoshimoto K. ( 2000) Multiple endocrine neoplasia type 1: from bedside to benchside. Journal of Medical Investigation, 47, 108 117.
31. Agarwal S.K. Burns A.L. Sukhodolets K.E. Kennedy P.A. Obungu V.H. Hickman A.B. Mullendore M.E. Whitten I. Skarulis M.C. Simonds W.F. Mateo C. Crabtree J.S. Scacheri P.C. Ji Y. Novotny E.A. Garrett-Beal L. Ward J.M. Libutti S.K. Alexander H.R. Cerrato A. Parisi M.J. Anna A.S.S. Oliver B. Chandrasekharappa S.C. Collins F.S. Spiegel A.M. Marx S.J. ( 2004) Molecular pathology of the MEN1 gene. Annals of the New York Academy of Sciences, 1014, 189 198.
32. Herman J.G. Baylin S.B. ( 2003) Gene silencing in cancer in association with promoter hypermethylation. New England Journal of Medicine, 349, 2042 2054.
33. Carlson K.M. Bracamontes J. Jackson C.E. Clark R. Lacroix A. Wells S.A. Jr. Goodfellow P.J. ( 1994) Parent-of-origin effects in multiple endocrine neoplasia type 2B. American Journal of Human Genetics, 55, 1076 1082.
34. Kakinuma A. Morimoto I. Nakano Y. Fujimoto R. Ishida O. Okada Y. Inokuchi N. Fujihira T. Eto S. ( 1994) Familial primary hyperparathyroidism complicated with Wilms' tumor. Internal Medicine, 33, 123 126.
35. Szabo J. Heath B. Hill V.M. Jackson C.E. Zarbo R.J. Mallette L.E. Chew S.L. Besser G.M. Thakker R.V. Huff V. Leppert M.F. Heath H. III ( 1995) Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. American Journal of Human Genetics, 56, 944 950.
36. Kishi M. Tsukada T. Shimizu S. Futami H. Ito Y. Kanbe M. Obara T. Yamaguchi K. ( 1998) A large germline deletion of the MEN1 gene in a family with multiple endocrine neoplasia type 1. Japanese Journal of Cancer Research, 89, 1 5.
37. Cavaco B.M. Domingues R. Bacelar M.C. Cardoso H. Barros L. Gomes L. Ruas M.M. Agapito A. Garrao A. Pannett A.A. Silva J.L. Sobrinho L.G. Thakker R.V. Leite V. ( 2002) Mutational analysis of Portuguese families with multiple endocrine neoplasia type 1 reveals large germline deletions. Clinical Endocrinology, 56, 465 473.